Navigation Links
PeaceHealth Standardizes Hematology Operations With Sysmex

MUNDELEIN, Ill., Feb. 8, 2011 /PRNewswire/ -- Sysmex America, Inc. today announced a five-year Equipment, Reagents, Q.C. and Service Agreement with PeaceHealth, a not-for-profit integrated healthcare network with medical centers, critical access hospitals, medical group clinics and laboratories located in Alaska, Washington and Oregon.  Based on each site's testing requirements, the agreement ensures either the installation of a Sysmex XE-5000™, Sysmex XE-2100™ or Sysmex XT-1800i™ Automated Hematology Analyzer at nine of the network's clinical laboratories.

The enhanced automation and technology standardization across multiple sites enables PeaceHealth the ability to shift personnel between hematology laboratories without the need to cross-train on different types of analyzers; the ability to withstand future medical technologists' shortages; and the ability to keep up with workload demands and testing complexity that may accompany an aging population.  PeaceHealth processes 730,000 blood samples annually.

Prior to this new contract, Sysmex was selected by Oregon Medical Laboratories (OML), Oregon State's largest reference laboratory owned and operated by PeaceHealth, to standardize hematology operations through the use of advanced robotics and specimen handling.  The first-of-its-kind automation enabled OML hands-free operation doubling its processing capacity.

"PeaceHealth is committed to process improvements that make a 'best-practice' difference in patient care across operations.  Even though our network's clinical laboratories have different testing requirements, PeaceHealth was able to purchase same-technology hematology equipment perfectly suited for each site. This same-technology standardization, coupled with the known reliability of Sysmex instruments, made Sysmex a perfect choice for our clinical laboratory process improvement initiatives," said Julie Halic, Chief Operations Officer at PeaceHealth Laboratories.  Sysmex innovation as evidenced by the development of advanced clinical parameters such as Immature Platelet Fraction (IPF), Reticulocyte Hemoglobin (RET-He) and the Immature Granulocyte (IG) count was also a key decision factor.  The decision to purchase Sysmex instruments was led by a cross-regional group of operations staff, managers and medical technologists.

"We believe Sysmex hematology solutions fit well with PeaceHealth's approach to collaborate and standardize best practices for ongoing improvement in patient care across operations. By standardizing instrument platforms, information integration, and advanced technologies, PeaceHealth's Laboratories will achieve unexpected levels of optimization for laboratory operations that literally transform productivity – all of which offers the enormous benefits of standardized care and consistency. Sysmex America is honored to be a PeaceHealth partner," said George Webber, Sr. Health System Account Manager, Sysmex America.

About PeaceHealth

PeaceHealth is a Bellevue, WA-based not-for-profit health care system with medical centers, critical access hospitals, medical group clinics and laboratories located in Alaska, Washington and Oregon. Founded by the Sisters of St. Joseph of Peace, PeaceHealth has provided exceptional medicine and compassionate care to Northwest communities for more than a century. During the most recent fiscal year (ended June 30, 2009), PeaceHealth provided patient care to these communities through more than 60,000 inpatient admissions, 500,000 outpatient registrations, and 1 million medical group encounters. PeaceHealth consistently receives national recognition for innovations in patient-centered care, patient safety, health care technology and cost efficiency.  For more information about PeaceHealth Laboratories, please visit

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems.  Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide.  For more information about Sysmex, please visit

SOURCE Sysmex America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals
2. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
3. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
4. Telik Announces Telintra Presentation at American Society of Hematology Annual Meeting
5. Genta Clinical Programs Featured at American Society of Hematology Meeting
6. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
7. PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting
8. Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting
9. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Long-Term Safety and Efficacy Data on Promacta(TM) (Eltrombopag) Presented at American Society of Hematology Annual Meeting
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):